ٍٍٍ½خر

header-logo
GettyImages-609179959-hero

Hereditary Hemorrhagic Telangiectasia (HHT) Genetic Counseling at the ٍٍٍ½خر

About the Program

Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu disease, is an inherited vascular disorder characterized by abnormal blood vessel formation, including telangiectasias and arteriovenous malformations (AVMs). Symptoms can vary widely among individuals and family members. Early diagnosis and ongoing management are important to reduce complications. Individuals with HHT benefit from evaluation and surveillance at specialized multidisciplinary centers experienced in HHT diagnosis, treatment, and care.

Our Hereditary Hemorrhagic Telangiectasia (HHT) Program is the only HHT Foundation International-designated Center of Excellence in Wisconsin and one of only a few in the Midwest. Our team collaborates with HHT centers nationwide to provide patients with access to expert care, advanced diagnostics, treatments, and clinical trial opportunities.

A male healthcare provider counseling a female patient

Hereditary Hemorrhagic Telangiectasia (HHT) Genetic Counseling Frequently Asked Questions

all
What complications can HHT cause?

Complications individuals with HHT may experience include:

  • Telangiectasias of the nose, which result in nosebleeds of varying severity (affects ~90% of people with HHT)
  • Telangiectasias of skin and hands, which are usually benign (affects ~90% of people with HHT)
  • Telangiectasias in the GI system that can lead to GI bleeding (affects ~30% of people with HHT); symptoms may include black/bloody stools or anemia
  • Pulmonary AVMs that increase risk for stroke or brain abscess and that can rupture (affects ~40% of people with HHT and can be present early in life)
  • Brain AVMs, which are thought to be present from birth and often do not cause warning symptoms prior to hemorrhage (affects ~10% of people with HHT)
  • Liver telangiectasias/AVMs, which are usually asymptomatic (occur in ~75% of HHT patients)
What benefits can HHT genetic testing provide?

Genetic testing can identify the specific genetic cause for HHT in someone with a clinical diagnosis (defined through the Curacao criteria) over 90% of the time. Genetic testing can also be helpful when a patient meets some but not all criteria for a clinical diagnosis of HHT and there is no (known) family history. Finally, genetic testing can also differentiate between a clinical diagnosis of HHT and a similar condition known as Capillary Malformation-Arteriovenous Malformation syndrome (CM-AVM).

When the specific variant (mutation) is known, genetic counselors can then help identify at-risk family members who may not meet all the diagnostic criteria. HHT is a dominant condition, meaning an affected individual has a 50% risk of passing down the diagnosis with each pregnancy.

It is important to note that a negative genetic testing result doesn't change a clinical diagnosis of HHT, as someone could have HHT due to a genetic mutation not detected with current testing. Having support from a genetic counselor can help individuals understand those limitations and stay up-to-date on the latest information on the diagnosis.

Genetic Counselor

headshot

Emma A. Kell, MS, CGC

Genetic Counselor

Contact Us

Genetic Counseling Program

ٍٍٍ½خر
Hub for Collaborative Medicine
8701 Watertown Plank Rd., 2nd Floor
Milwaukee, WI 53226

ج‎

Make an Appointment
(414) 777-7700